×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [4]
Institute of Chi... [1]
Authors
LUO QIAN [1]
ZHAO QI [1]
OUYANG DEFANG [1]
Document Type
Journal article [3]
Conference paper [1]
Date Issued
2024 [1]
2020 [2]
2016 [1]
Language
英語English [4]
Source Publication
Cancer Letters [2]
Antibodies [1]
Highly Stable an... [1]
Indexed By
ESCI [1]
SCIE [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-4 of 4
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Title Ascending
Title Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Submit date Ascending
Submit date Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Issue Date Ascending
Issue Date Descending
Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells
Journal article
Zhou, Guangyu, Fu, Shengyu, Zhang, Yunsen, Li, Shuang, Guo, Ziang, Ouyang, Defang, Ying, Tianlei, Lu, Yinying, Zhao, Qi. Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells[J]. Antibodies, 2024, 13(2), 45.
Authors:
Zhou, Guangyu
;
Fu, Shengyu
;
Zhang, Yunsen
;
Li, Shuang
;
Guo, Ziang
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
3.0
/
4.7
|
Submit date:2024/08/05
Her2
Monoclonal Antibody
Car-t Cell
Trastuzumab
Acetyltanshinone IIA is more potent than lapatinib in inhibiting cell growth and degrading HER2 protein in drug-resistant HER2-positive breast cancer cells
Journal article
Huang, Bin, Yip,Wai Kien, Wei, Na, Luo, Kathy Qian. Acetyltanshinone IIA is more potent than lapatinib in inhibiting cell growth and degrading HER2 protein in drug-resistant HER2-positive breast cancer cells[J]. Cancer Letters, 2020, 490, 1-11.
Authors:
Huang, Bin
;
Yip,Wai Kien
;
Wei, Na
;
Luo, Kathy Qian
Favorite
|
TC[WOS]:
8
TC[Scopus]:
8
IF:
9.1
/
8.3
|
Submit date:2021/03/02
Acetyltanshinone Iia
Drug Resistance
Her2 Degradation
Her2-positive Breast Cancer
Acetyltanshinone IIA is more potent than lapatinib in inhibiting cell growth and degrading HER2 protein in drug-resistant HER2-positive breast cancer cells
Journal article
Huang, B, Yip, WK, Na, W, Luo, KQ. Acetyltanshinone IIA is more potent than lapatinib in inhibiting cell growth and degrading HER2 protein in drug-resistant HER2-positive breast cancer cells[J]. Cancer Letters, 2020, 1-11.
Authors:
Huang, B
;
Yip, WK
;
Na, W
;
Luo, KQ
Favorite
|
IF:
9.1
/
8.3
|
Submit date:2022/08/26
Acetyltanshinone IIA
drug resistance
HER2-positive breast cancer
HER2 degradation
中国化学会第30届学术年会
Conference paper
Wu, Y., Chen, Z., Zhang, P., Li, C., Zhou, L., Jiang, T., Gong, P., Zhao, Q., Cai, L.. 中国化学会第30届学术年会[C], 2016.
Authors:
Wu, Y.
;
Chen, Z.
;
Zhang, P.
;
Li, C.
;
Zhou, L.
; et al.
Favorite
|
|
Submit date:2023/08/30
聚合物点
点击化学
Her2受体
纳米探针
荧光成像